This latter finding is particularly pertinent to BC, where p53 is relatively less frequently mutated compared with other types of tumors, and loss of WT p53 activity may depend on alterations of several upstream regulatory pathways (Gasco et al, 2002; Dumay et al, 2013). Here, TP53 is linked to breast cancer.